BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 19071177)

  • 21. Laser mimicking mosquito bites for skin delivery of malaria sporozoite vaccines.
    Zhou C; Chen X; Zhang Q; Wang J; Wu MX
    J Control Release; 2015 Apr; 204():30-7. PubMed ID: 25725360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver or blood-stage arrest during malaria sporozoite immunization: the later the better?
    Nganou-Makamdop K; Sauerwein RW
    Trends Parasitol; 2013 Jun; 29(6):304-10. PubMed ID: 23608185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetically modified Plasmodium parasites as a protective experimental malaria vaccine.
    Mueller AK; Labaied M; Kappe SH; Matuschewski K
    Nature; 2005 Jan; 433(7022):164-7. PubMed ID: 15580261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasmodium: mammalian codon optimization of malaria plasmid DNA vaccines enhances antibody responses but not T cell responses nor protective immunity.
    Dobaño C; Sedegah M; Rogers WO; Kumar S; Zheng H; Hoffman SL; Doolan DL
    Exp Parasitol; 2009 Jun; 122(2):112-23. PubMed ID: 19249301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The whole parasite, pre-erythrocytic stage approach to malaria vaccine development: a review.
    Epstein JE; Richie TL
    Curr Opin Infect Dis; 2013 Oct; 26(5):420-8. PubMed ID: 23982233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessing the adequacy of attenuation of genetically modified malaria parasite vaccine candidates.
    Annoura T; Ploemen IH; van Schaijk BC; Sajid M; Vos MW; van Gemert GJ; Chevalley-Maurel S; Franke-Fayard BM; Hermsen CC; Gego A; Franetich JF; Mazier D; Hoffman SL; Janse CJ; Sauerwein RW; Khan SM
    Vaccine; 2012 Mar; 30(16):2662-70. PubMed ID: 22342550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A genetically attenuated malaria vaccine candidate based on P. falciparum b9/slarp gene-deficient sporozoites.
    van Schaijk BC; Ploemen IH; Annoura T; Vos MW; Foquet L; van Gemert GJ; Chevalley-Maurel S; van de Vegte-Bolmer M; Sajid M; Franetich JF; Lorthiois A; Leroux-Roels G; Meuleman P; Hermsen CC; Mazier D; Hoffman SL; Janse CJ; Khan SM; Sauerwein RW
    Elife; 2014 Nov; 3():. PubMed ID: 25407681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenicity of Plasmodium yoelii merozoite surface protein 4/5 produced in transgenic plants.
    Wang L; Webster DE; Campbell AE; Dry IB; Wesselingh SL; Coppel RL
    Int J Parasitol; 2008 Jan; 38(1):103-10. PubMed ID: 17681344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of hepatic inflammatory response by Plasmodium berghei sporozoites protects BALB/c mice against challenge with Plasmodium yoelii sporozoites.
    Vanderberg JP; Khan ZM; Stewart MJ
    J Parasitol; 1993 Oct; 79(5):763-7. PubMed ID: 8410550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Plasmodium Parasite with Complete Late Liver Stage Arrest Protects against Preerythrocytic and Erythrocytic Stage Infection in Mice.
    Vaughan AM; Sack BK; Dankwa D; Minkah N; Nguyen T; Cardamone H; Kappe SHI
    Infect Immun; 2018 May; 86(5):. PubMed ID: 29440367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Live attenuated malaria vaccine designed to protect through hepatic CD8⁺ T cell immunity.
    Epstein JE; Tewari K; Lyke KE; Sim BK; Billingsley PF; Laurens MB; Gunasekera A; Chakravarty S; James ER; Sedegah M; Richman A; Velmurugan S; Reyes S; Li M; Tucker K; Ahumada A; Ruben AJ; Li T; Stafford R; Eappen AG; Tamminga C; Bennett JW; Ockenhouse CF; Murphy JR; Komisar J; Thomas N; Loyevsky M; Birkett A; Plowe CV; Loucq C; Edelman R; Richie TL; Seder RA; Hoffman SL
    Science; 2011 Oct; 334(6055):475-80. PubMed ID: 21903775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection.
    Lyke KE; Ishizuka AS; Berry AA; Chakravarty S; DeZure A; Enama ME; James ER; Billingsley PF; Gunasekera A; Manoj A; Li M; Ruben AJ; Li T; Eappen AG; Stafford RE; Kc N; Murshedkar T; Mendoza FH; Gordon IJ; Zephir KL; Holman LA; Plummer SH; Hendel CS; Novik L; Costner PJ; Saunders JG; Berkowitz NM; Flynn BJ; Nason MC; Garver LS; Laurens MB; Plowe CV; Richie TL; Graham BS; Roederer M; Sim BK; Ledgerwood JE; Hoffman SL; Seder RA
    Proc Natl Acad Sci U S A; 2017 Mar; 114(10):2711-2716. PubMed ID: 28223498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Escheriosome entrapped soluble blood stage antigens impart protective immunity against a multi-drug resistant isolate of Plasmodium yoelii nigeriensis in BALB/c mice.
    Sharma SK; Farah D; Misra-Bhattacharya S; Bajpai P; Agarwal A; Mohammad O
    Vaccine; 2006 Feb; 24(7):948-56. PubMed ID: 16168527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new approach to generate a safe double-attenuated Plasmodium liver stage vaccine.
    Nagel A; Prado M; Heitmann A; Tartz S; Jacobs T; Deschermeier C; Helm S; Stanway R; Heussler V
    Int J Parasitol; 2013 May; 43(6):503-14. PubMed ID: 23500072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunization of Malaria-Preexposed Volunteers With PfSPZ Vaccine Elicits Long-Lived IgM Invasion-Inhibitory and Complement-Fixing Antibodies.
    Zenklusen I; Jongo S; Abdulla S; Ramadhani K; Lee Sim BK; Cardamone H; Flannery EL; Nguyen T; Fishbaugher M; Steel RWJ; Betz W; Carmago N; Mikolajczak S; Kappe SHI; Hoffman SL; Sack BK; Daubenberger C
    J Infect Dis; 2018 Apr; 217(10):1569-1578. PubMed ID: 29438525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaxfectin enhances immunogenicity and protective efficacy of P. yoelii circumsporozoite DNA vaccines.
    Sedegah M; Rogers WO; Belmonte A; Belmonte M; Banania G; Patterson N; Ferrari M; Kaslow DC; Carucci DJ; Richie TL; Doolan DL
    Vaccine; 2006 Mar; 24(11):1921-7. PubMed ID: 16298024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A First for Human Vaccinology: GMP Compliant Radiation Attenuation of
    James ER; Matheny S; Overby J; Sim BKL; Eappen AG; Li T; Li ML; Richie TL; Chakravarty S; Gunasekera A; Murshedkar T; Billingsley PF; Hoffman SL
    Front Immunol; 2022; 13():851028. PubMed ID: 35242146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites.
    Hoffman SL; Goh LM; Luke TC; Schneider I; Le TP; Doolan DL; Sacci J; de la Vega P; Dowler M; Paul C; Gordon DM; Stoute JA; Church LW; Sedegah M; Heppner DG; Ballou WR; Richie TL
    J Infect Dis; 2002 Apr; 185(8):1155-64. PubMed ID: 11930326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The intradermal route for inoculation of sporozoites of rodent malaria parasites for immunological studies.
    Inoue M; Culleton RL
    Parasite Immunol; 2011 Feb; 33(2):137-42. PubMed ID: 21226727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunization of mice with live-attenuated late liver stage-arresting Plasmodium yoelii parasites generates protective antibody responses to preerythrocytic stages of malaria.
    Keitany GJ; Sack B; Smithers H; Chen L; Jang IK; Sebastian L; Gupta M; Sather DN; Vignali M; Vaughan AM; Kappe SH; Wang R
    Infect Immun; 2014 Dec; 82(12):5143-53. PubMed ID: 25267837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.